These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15705087

  • 1. Brachytherapy-related dysuria.
    Merrick GS, Butler WM, Wallner KE, Allen Z, Galbreath RW, Lief JH.
    BJU Int; 2005 Mar; 95(4):597-602. PubMed ID: 15705087
    [Abstract] [Full Text] [Related]

  • 2. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.
    Allen ZA, Merrick GS, Butler WM, Wallner KE, Kurko B, Anderson RL, Murray BC, Galbreath RW.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):981-7. PubMed ID: 15989998
    [Abstract] [Full Text] [Related]

  • 3. The impact of radiation dose to the urethra on brachytherapy-related dysuria.
    Merrick GS, Butler WM, Wallner KE, Allen ZA, Galbreath RW, Lief JH, Reed DJ.
    Brachytherapy; 2005 Jul 15; 4(1):45-50. PubMed ID: 15737906
    [Abstract] [Full Text] [Related]

  • 4. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
    Niehaus A, Merrick GS, Butler WM, Wallner KE, Allen ZA, Galbreath RW, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):136-43. PubMed ID: 16198062
    [Abstract] [Full Text] [Related]

  • 5. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
    Gutman S, Merrick GS, Butler WM, Wallner KE, Allen Z, Galbreath RW, Adamovich E.
    BJU Int; 2006 Jan 01; 97(1):62-8. PubMed ID: 16336330
    [Abstract] [Full Text] [Related]

  • 6. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
    Hinerman-Mulroy A, Merrick GS, Butler WM, Wallner KE, Allen Z, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1367-82. PubMed ID: 15275722
    [Abstract] [Full Text] [Related]

  • 7. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
    Keyes M, Miller S, Moravan V, Pickles T, McKenzie M, Pai H, Liu M, Kwan W, Agranovich A, Spadinger I, Lapointe V, Halperin R, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1023-32. PubMed ID: 19111402
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Lief JH, Galbreath RW.
    Urology; 2002 Oct 15; 60(4):650-5. PubMed ID: 12385927
    [Abstract] [Full Text] [Related]

  • 9. Dysuria after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Murray B, Zeroski D, Lief JH.
    Int J Radiat Oncol Biol Phys; 2003 Mar 15; 55(4):979-85. PubMed ID: 12605976
    [Abstract] [Full Text] [Related]

  • 10. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Murray B, Allen Z, Lief JH, Galbreath RW.
    Brachytherapy; 2004 Mar 15; 3(1):22-9. PubMed ID: 15110310
    [Abstract] [Full Text] [Related]

  • 11. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M, Studer G, Le L, McLean M, Yeung I, Pond G, Crook JM.
    Brachytherapy; 2007 Mar 15; 6(3):173-9. PubMed ID: 17681239
    [Abstract] [Full Text] [Related]

  • 12. Selecting patients with pretreatment postvoid residual urine volume less than 100 mL may favorably influence brachytherapy-related urinary morbidity.
    Beekman M, Merrick GS, Butler WM, Wallner KE, Allen ZA, Galbreath RW.
    Urology; 2005 Dec 15; 66(6):1266-70. PubMed ID: 16360455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Kurko B, Cleavinger S.
    Brachytherapy; 2003 Dec 15; 2(3):147-57. PubMed ID: 15062137
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA, Stock RG, Cesaretti J, Stone NN.
    J Urol; 2005 Mar 15; 173(3):808-12. PubMed ID: 15711274
    [Abstract] [Full Text] [Related]

  • 19. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN, Stock RG.
    Brachytherapy; 2003 Mar 15; 2(1):32-9. PubMed ID: 15062161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.